Annexon Biosciences
Brisbane, California, United StatesBiotechB2Bannexonbio.com
Unlocking the next generation of complement therapies We are focused on stopping C1q, the initiating molecule of the classical complement pathway, at the start to treat devastating autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain and eye. Our science We target C1q to block all damaging components of the immune system’s classical complement pathway. Learn more Our pipeline
Funding and hiring
- Funding
- PublicSource
- Hiring now
- 7 open roles · board read Oct 2, 2026
- Other 5Legal 1Marketing 1
On-site 7
Roles in United States
Founders and contacts
- Founders1 name, locked
- Founder emailsBeing confirmed, locked
- LinkedInCompany page, locked
- Careers pageOpen roles, locked
- Office addressStreet address, locked
Explore
More startups in Brisbane
.png){kind=logo}
Are you a founder of Annexon Biosciences and want your details removed? Write to us and we remove them within 72 hours.